MAPK3 and Myocardial fibrosis: IL-17 activates the protein kinase C (PKC)β/extracellular signal-regulated kinase 1/2 (ERK1/2)/nuclear factor-κB (NF-κB)-dependent signaling pathway to aggravate the degree of myocardial fibrosis (65).